Biopharma Executive Rick Crowley Joins Novavax as Chief Operations Officer
December 21, 2020 17:42 ET
|
Novavax, Inc.
GAITHERSBURG, Md., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 Vaccine
December 16, 2020 19:08 ET
|
Novavax, Inc.
GAITHERSBURG, Md., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax Appoints Vaccine Industry Expert Margaret G. McGlynn to Board of Directors
December 09, 2020 08:02 ET
|
Novavax, Inc.
GAITHERSBURG, Md., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax Announces COVID-19 Vaccine Clinical Development Progress
November 30, 2020 06:30 ET
|
Novavax, Inc.
Pivotal Phase 3 trial in United Kingdom completes enrollmentPhase 2b efficacy trial in South Africa completes enrollment U.S./Mexico Phase 3 trial expected to begin in the coming weeks ...
Novavax to Participate in Upcoming Conferences
November 25, 2020 16:15 ET
|
Novavax, Inc.
GAITHERSBURG, Md., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Novavax Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax to Host Conference Call for Questions Related to Third Quarter Financial and Operating Results on November 10, 2020
November 10, 2020 09:18 ET
|
Novavax, Inc.
GAITHERSBURG, Md., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, will host a...
Novavax Reports Third Quarter 2020 Financial and Operational Results
November 09, 2020 16:05 ET
|
Novavax, Inc.
Advanced clinical development of NVX‑CoV2373 with initiation of first Phase 3 trial to evaluate efficacy, safety and immunogenicityU.K. Phase 3 interim data expected as soon as early first quarter...
Novavax Appoints Gregory F. Covino as Chief Financial Officer and Announces Leadership Updates
November 09, 2020 16:02 ET
|
Novavax, Inc.
Covino brings global biopharmaceutical finance experience to NovavaxJohn Trizzino, Chief Business Officer, takes on additional role as Chief Commercial OfficerFilip Dubovsky, M.D. promoted to...
Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA
November 09, 2020 08:30 ET
|
Novavax, Inc.
GAITHERSBURG, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax and Commonwealth of Australia Announce Agreement in Principle for Acquisition of Novavax COVID-19 Vaccine
November 04, 2020 09:52 ET
|
Novavax, Inc.
GAITHERSBURG, Md., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...